Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CURE vs. METD: which is better?

Bottom line

CURE vs METD: the short answer

CURE (Direxion Daily Healthcare Bull 3X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs.

But CURE is far broader, holding 67 positions to 8 for METD, so beyond the top names it adds exposure METD doesn't have.

CURE is cheaper at 0.94% vs 1.02% — a difference of $8.00 a year per $10,000 invested.

Over one year, CURE returned +22.9% vs −17.3% for METD.

Updated Nov 19, 2026

CURE vs METD side by side

CUREMETD
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.94%1.02%
Annual cost per $10k$94$102
10-yr cost on $10k (prospectus)$1,155$1,428
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+22.9%−17.3%
5-yr return (annualized)+8.6%—
10-yr return (annualized)+13.6%—
Best quarter+46.9%+10.1%
Worst quarter−45.8%−25.5%
Net assets (fund)$171.7M$10.8M
Number of holdings678
Portfolio turnover1%%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearCUREMETDDifference
2025+22.9%−17.3%+40.2%

Source: Fund prospectus bar charts

Holdings overlap

6 of CURE's top 25 holdings also appear in METD's top 8.

Shared top holdings
HoldingCUREMETD
Dreyfus18.79%67.68%
N/a8.28%1.07%
Goldman Sachs Liq Es Fd A8.19%12.14%
Goldman Financial7.51%17.87%
N/a3.34%1.07%
N/a1.12%1.07%

Source: SEC Form N-PORT

CURE top 10

  1. Dreyfus — 18.79%
  2. Eli Lilly & Company — 10.41%
  3. N/a — 8.28%
  4. Goldman Sachs Liq Es Fd A — 8.19%
  5. Goldman Financial — 7.51%
  6. Johnson & Johnson — 7.07%
  7. Abbvie Inc — 5.08%
  8. Unitedhealth Group Inc — 4.31%
  9. Merck & Company Inc — 3.68%
  10. N/a — 3.34%

METD top 10

  1. Dreyfus — 67.68%
  2. Goldman Financial — 17.87%
  3. Goldman Sachs Liq Es Fd A — 12.14%
  4. Dreyfus — 3.99%
  5. N/a — 3.73%
  6. N/a — 2.57%
  7. N/a — 2.23%
  8. N/a — 1.07%

FAQ

What is the difference between CURE and METD?
CURE (Direxion Daily Healthcare Bull 3X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs. But CURE is far broader, holding 67 positions to 8 for METD, so beyond the top names it adds exposure METD doesn't have.
Which is cheaper, CURE or METD?
CURE has the lower expense ratio (0.94%).
Should I own both CURE and METD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.